# Pristinamycin in the Treatment of MSSA Bone and Joint Infection

> **NCT03177343** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 102 (actual)

## Conditions studied

- Methicillin Susceptible Staphylococcus Aureus (MSSA) Infection
- Bone and Joint Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03177343
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03177343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03177343, "Pristinamycin in the Treatment of MSSA Bone and Joint Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03177343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*